Trevo NXT ProVue Retriever
FDA 510(k) K200117 · Stryker
510(k) numberK200117
Submission
- Device name
- Trevo NXT ProVue Retriever
- Applicant
- Stryker
Fremont, CA, US - Received
- January 21, 2020
- Decision date
- February 7, 2020
- Decision
- Substantially Equivalent (SESE)
- Type
- Special 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- POL – Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 882.5600
- Specialty
- Neurology
A neurovascular mechanical thrombectomy device for acute ischemic stroke treatment is a prescription device used in the treatment of acute ischemic stroke to improve clinical outcomes. The device is delivered into the neurovasculature with an endovascular approach, mechanically removes thrombus from the body, and restores blood flow in the neurovasculature.
Other 510(k)s with product code POL
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K242676 | pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy DevicePOL · Special | Phenox Limited | 02/28/2025SE |
| K231539 | pRESET LITE Thrombectomy DevicePOL · Traditional | Phenox Limited | 10/21/2023SE |
| K223305 | Trevo NXT ProVue RetrieverPOL · Traditional | Stryker Neurovascular | 03/29/2023SE |
| K222848 | pRESET Thrombectomy DevicePOL · Traditional | Phenox Limited | 01/20/2023SE |
| K210502 | Trevo NXT ProVue RetrieverPOL · Traditional | Stryker Neurovascular | 08/27/2021SE |
| K203358 | Solitaire X Revascularization DevicePOL · Traditional | Micro Therapeutics, Inc. d/b/a ev3 Neurovascular | 03/01/2021SE |
| K203219 | Trevo XP ProVue Retriever and Trevo NXT ProVue RetrieverPOL · Traditional | Stryker Neurovascular | 12/29/2020SE |
| K193576 | Solitaire Platinum Revascularization Device, Solitaire X Revascularization Device…POL · Traditional | Micro Therapeutics, Inc. d/b/a ev3 Neurovascular | 11/20/2020SE |
| K192207 | Trevo NXT ProVue RetrieverPOL · Traditional | Stryker | 11/22/2019SE |
| K190779 | Trevo XP ProVue RetrieverPOL · Traditional | Stryker | 06/25/2019SE |
More from Stryker
| 510(k) | Device | Decision |
|---|---|---|
| K261481 | Pangea Femur Reconstruction SystemHSB · Traditional | 06/29/2026SE |
| K253640 | T2 Alpha Femur Retrograde Nailing System; Pangea Femur Reconstruction SystemHSB · Traditional | 02/03/2026SE |
| K253202 | Hoffmann LRF SystemKTT · Traditional | 12/19/2025SE |
| K251400 | T2 Alpha Humerus Nailing System; IMN Screws System; T2 Nailing SystemHSB · Traditional | 08/20/2025SE |
| K250163 | T2 Alpha Femur Retrograde Nailing SystemHSB · Traditional | 08/13/2025SE |
| K242445 | Pangea Platform; Pangea Femur Plating System; Pangea Humerus Plating System; Pangea…HRS · Traditional | 10/06/2024SE |
| K233919 | VariAx 2 Distal Radius SystemHRS · Traditional | 03/25/2024SE |
| K233741 | Hoffmann LRF SystemKTT · Special | 12/21/2023SE |
| K230045 | HipCheckQIH · Traditional | 09/29/2023SE |
| K231854 | 1788 4K Camera System with Advanced Imaging Modality; L12 LED Light Source with AIMOWN · Traditional | 09/20/2023SE |
Questions and answers
When was Trevo NXT ProVue Retriever cleared by the FDA?
Trevo NXT ProVue Retriever (K200117) received a 510(k) decision of Substantially Equivalent on February 7, 2020, 17 days after the submission was received.
What is the product code of K200117?
The FDA product code is POL – Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment, a Class II (moderate risk) device regulated under 21 CFR 882.5600.